TruAlt Bioenergy Q2 & H1 FY27 Financial and Operational Performance
Trualt Bioenergy Ltd · Investor Presentation · 24 Oct 2026, 2:39 am
TruAlt Bioenergy Q2 & H1 FY27 Financial and Operational Performance TruAlt Bioenergy reported strong consolidated growth for H1 FY27, with total income surging 221% YoY to ₹1,465.14 Cr and EBITDA jumping 532% YoY to ₹233.92 Cr (margin at 16.27%). PAT swung to ₹94.27 Cr from a loss of ₹33.27 Cr in H1 FY26. For Q2 FY27, total income reached ₹823.74 Cr, EBITDA stood at ₹101.16 Cr, and PAT reached ₹34.99 Cr. Growth was led by ethanol operations, which contributed ₹1,262.64 Cr in revenue, supported by 2,000 KLPD capacity with 1,300 KLPD dual-feed integration.
Original exchange filing (PDF)
More announcements from Trualt Bioenergy Ltd
- Intimation regarding receipt of allocation for Supply of Ethanol - ESY 2026-27 · 13 Nov 2026
- Monitoring Agency Report for the quarter ended on September 30, 2026. · 31 Oct 2026
- Earnings Call Transcript · 29 Oct 2026
- Intimation of recording of earnings call held on 26 October 2026 · 26 Oct 2026
- Results-Financial Results for September 30,2026. · 24 Oct 2026
- Press Release under Regulation 30 of SEBI (LODR) Regulations 2015 · 24 Oct 2026
- Outcome of Board Meeting for approval of Unaudited Financial Results(Standalone and Consolidated) along with Limited Review Report thereon, for the Quarter and Half Year ended on September 30, 2026. · 24 Oct 2026
- TruAlt Bioenergy Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 24 Oct 2026
